Christopher Heery Sells $291K of Arcellx Inc (ACLX) — SEC Form 4, Sep 19, 2025
Open-Market Net Sale · SEC Form 4
−$291,468
10b5-1 Plan
Equity position changed by -9.7%
Equity Position
34.1K sh
37,770 → 34,127
Equity Change
-9.7%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Christopher Heery CIK 0001789632 |
Officer
|
Christopher Heery at Arcellx Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,314,096
More from this insider at Arcellx Inc
| 2026-04-28 | Award | — | View |
| 2026-01-14 | Sell | -$402,997 | View |
| 2026-01-14 | Sell | -$487,213 | View |
| 2026-01-12 | Sell | -$393,286 | View |
| 2026-01-07 | Exercise | — | View |
Non-Derivative Securities Transactions
Footnotes (3)
- F1
- The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 23, 2025. Show more
- F2
- Represents the weighted average share price of an aggregate total of 3,343 shares sold in the price range of $80.00 to $80.055 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Show more
- F3
- Includes 284 shares acquired under the Issuer's 2022 Employee Stock Purchase Plan on May 14, 2025. Show more
Related filings at Arcellx Inc
Institutional Holders
13F holders · Jun 30, 2026
2
institutional managers reporting a position
Largest by reported value
- Deka Bank Deutsche Girozentrale $3.43M
- Ifp Advisors, Inc $1.5K
5%+ Holders · 13D/G
2 filers
-
Gilead Sciences, Inc. 100.0%
-
Black Rock, Inc. 6.4%
Other insiders at Arcellx Inc
GET /v1/forms/4/0001789632-25-000005
API docs
View Original SEC Filing